Share chart Precigen, Inc.
Extended chart
Simple chart
About Precigen, Inc.
Precigen, Inc. открывает и разрабатывает генные и клеточные методы лечения нового поколения в Соединенных Штатах. Он также предоставляет терапевтические средства, модифицирующие заболевание; генно-инженерные свиньи для применения в регенеративной медицине; собственная платформа биоконверсии метана, которая превращает природный газ в энергию и химические продукты; и репродуктивные технологии и технологии переноса эмбрионов. more details| IPO date | 2013-08-08 |
|---|---|
| ISIN | US74017N1054 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.precigen.com |
| Цена ао | 1.18 |
| Change price per day: | +3.73% (1.34) |
|---|---|
| Change price per week: | +25.23% (1.11) |
| Change price per month: | +75.95% (0.79) |
| Change price per 3 month: | +63.53% (0.85) |
| Change price per half year: | -8.55% (1.52) |
| Change price per year: | +0.7246% (1.38) |
| Change price per 3 year: | -40.09% (2.32) |
| Change price per 5 year: | -36.82% (2.2) |
| Change price per 10 year: | 0% (1.39) |
| Change price per year to date: | +101.39% (0.6902) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Patient Capital Management, LLC | 15983700 | 6.42 |
| Blackrock Inc. | 11120120 | 4.47 |
| Vanguard Group Inc | 6748359 | 2.71 |
| Geode Capital Management, LLC | 3021297 | 1.21 |
| Millennium Management LLC | 2845911 | 1.14 |
| State Street Corporation | 2684533 | 1.08 |
| Iridian Asset Management LLC | 2004934 | 0.81 |
| JP Morgan Chase & Company | 1343276 | 0.54 |
| Morgan Stanley | 1264309 | 0.51 |
| Northern Trust Corporation | 1082452 | 0.43 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Range Cancer Therapeutics ETF | 0.99388 | 47.24 | 0.11955 |
| Virtus LifeSci Biotech Clinical Trials ETF | 0.46353 | 63.04 | 0.33 |
| WisdomTree BioRevolution Fund | 0.24129 | -4.69 | 0.78691 |
| iShares Micro-Cap ETF | 0.03186 | 17.09 | 1.54048 |
| Invesco Nasdaq Biotechnology ETF | 0.02602 | 28.58 | 0.8565 |
| Principal Healthcare Innovators ETF | 0.0257 | 618.5 | 0.8416 |
| Future Tech ETF | 0.0257 | 426.34 | 0.8416 |
| ProShares Ultra Nasdaq Biotechnology | 0.01745 | 51.7 | 0.85651 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
Schwab U.S. Small-Cap ETF
|
0.00348 | 17.47 | 1.51433 |
ProShares UltraPro Russell2000
|
0.00272 | 89.82 | 1.47873 |
iShares Russell 2000 Growth ETF
|
0.00082 | 38.04 | 0.6026 |
| ProShares Hedge Replication ETF | 0.00081 | 5.92 | 1.47892 |
| iShares Russell 3000 ETF | 0.00041 | 24.83 | 1.43482 |
Schwab U.S. Broad Market ETF
|
0.00034 | 24.86 | 1.43354 |
| Vanguard Russell 2000 Growth ETF | 0 | 23.05 | 0.60264 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Rutul R. Shah | Chief Operating Officer | 393.54k | 1981 (44 years) |
| Mr. Steven Harasym | VP & Head of Investor Relations | N/A | |
| Mr. Harry Thomasian Jr. | Chief Financial Officer | 524.04k | 1962 (63 years) |
| Mr. Randal J. Kirk J.D. | Executive Chairman | 100k | 1953 (72 years) |
| Mr. Rob Russell | VP & Head of Human Resources | N/A | |
| Dr. Douglas E. Brough Ph.D. | Senior VP & Head of Research | N/A | 1955 (70 years) |
| Dr. Bryan T. Butman Ph.D. | Senior VP & Head of CMC | N/A | 1953 (72 years) |
| Dr. Helen Sabzevari MPH, Ph.D. | President, CEO & Director | 1962 (63 years) | |
| Mr. Donald P. Lehr J.D., Ph.D. | Chief Legal Officer & Corporate Secretary | 1975 (50 years) | |
| Mr. Jeffrey Thomas Perez J.D. | Senior Vice President of Intellectual Property Affairs | 1972 (53 years) |
Address: United States, Germantown, MD , 20374 Seneca Meadows Parkway - open in Google maps, open in Yandex maps
Website: https://www.precigen.com
Website: https://www.precigen.com
